Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Department of Pediatrics, University of Texas Medical Branch, Galveston, Texas, USA.
J Virol. 2019 Feb 5;93(4). doi: 10.1128/JVI.01721-18. Print 2019 Feb 15.
Reactivation of herpes simplex virus 2 (HSV-2) results in infection of epithelial cells at the neuro-epithelial junction and shedding of virus at the epithelial surface. Virus shedding can occur in either the presence or absence of clinical disease and is usually of short duration, although the shedding frequency varies among individuals. The basis for host control of virus shedding is not well understood, although adaptive immune mechanisms are thought to play a central role. To determine the importance of CD4 T cells in control of HSV-2 shedding, this subset of immune cells was depleted from HSV-2-infected guinea pigs by injection of an anti-CD4 monoclonal antibody (MAb). Guinea pigs were treated with the depleting MAb after establishment of a latent infection, and vaginal swabs were taken daily to monitor shedding by quantitative PCR. The cumulative number of HSV-2 shedding days and the mean number of days virus was shed were significantly increased in CD4-depleted compared to control-treated animals. However, there was no difference in the incidence of recurrent disease between the two treatment groups. Serum antibody levels and the number of HSV-specific antibody-secreting cells in secondary lymphoid tissues were unaffected by depletion of CD4 T cells; however, the frequency of functional HSV-specific, CD8 gamma interferon-secreting cells was significantly decreased. Together, these results demonstrate an important role for CD4 T lymphocytes in control of virus shedding that may be mediated in part by maintenance of HSV-specific CD8 T cell populations. These results have important implications for development of therapeutic vaccines designed to control HSV-2 shedding. Sexual transmission of HSV-2 results from viral shedding following reactivation from latency. The immune cell populations and mechanisms that control HSV-2 shedding are not well understood. This study examined the role of CD4 T cells in control of virus shedding using a guinea pig model of genital HSV-2 infection that recapitulates the shedding of virus experienced by humans. We found that the frequency of virus-shedding episodes, but not the incidence of clinical disease, was increased by depletion of CD4 T cells. The HSV-specific antibody response was not diminished, but frequency of functional HSV-reactive CD8 T cells was significantly diminished by CD4 depletion. These results confirm the role of cell-mediated immunity and highlight the importance of CD4 T cells in controlling HSV shedding, suggesting that therapeutic vaccines designed to reduce transmission by controlling HSV shedding should include specific enhancement of HSV-specific CD4 T cell responses.
单纯疱疹病毒 2 型(HSV-2)的再激活导致神经上皮交界处的上皮细胞感染和上皮表面的病毒脱落。病毒脱落可发生在有或没有临床疾病的情况下,通常持续时间短,尽管个体之间的脱落频率不同。宿主对病毒脱落的控制机制尚不清楚,尽管适应性免疫机制被认为发挥着核心作用。为了确定 CD4 T 细胞在控制 HSV-2 脱落中的重要性,通过注射抗 CD4 单克隆抗体(MAb)从 HSV-2 感染的豚鼠中耗尽这种免疫细胞亚群。在潜伏感染建立后,用耗竭 MAb 治疗豚鼠,并通过定量 PCR 每天采集阴道拭子以监测脱落情况。与对照治疗动物相比,CD4 耗尽的动物中 HSV-2 脱落天数的累积数和病毒脱落天数的平均值显着增加。然而,两组治疗之间的复发性疾病发生率没有差异。血清抗体水平和次级淋巴组织中 HSV 特异性抗体分泌细胞的数量不受 CD4 T 细胞耗竭的影响;然而,功能性 HSV 特异性 CD8 γ干扰素分泌细胞的频率显着降低。这些结果共同表明 CD4 T 淋巴细胞在控制病毒脱落中起着重要作用,这可能部分通过维持 HSV 特异性 CD8 T 细胞群来介导。这些结果对开发旨在控制 HSV-2 脱落的治疗性疫苗具有重要意义。HSV-2 通过潜伏感染后的再激活从潜伏状态中脱落,从而导致性传播。控制 HSV-2 脱落的免疫细胞群和机制尚不清楚。本研究使用生殖器 HSV-2 感染的豚鼠模型研究了 CD4 T 细胞在控制病毒脱落中的作用,该模型重现了人类经历的病毒脱落。我们发现,通过耗尽 CD4 T 细胞,病毒脱落发作的频率增加,但临床疾病的发生率没有增加。HSV 特异性抗体反应没有减弱,但 CD4 耗竭显着降低了功能性 HSV 反应性 CD8 T 细胞的频率。这些结果证实了细胞介导免疫的作用,并强调了 CD4 T 细胞在控制 HSV 脱落中的重要性,这表明旨在通过控制 HSV 脱落来减少传播的治疗性疫苗应包括对 HSV 特异性 CD4 T 细胞反应的特异性增强。